Doha – April 3, 2024: Students at Weill Cornell Medicine-Qatar (WCM-Q) have published a series of papers investigating the efficacy of microbiome-modulating therapeutics such as probiotics, prebiotics and synbiotics for managing type 2 diabetes.
Over a period of two years from 2021 to 2023, medical and pre-medical students at WCM-Q screened more than 10,000 scientific publications to collect, summarize and present results from randomized control trials.
The resulting papers were published in world-renowned, peer-reviewed scientific journals in the fields of metabolism, nutrition and pharmacology, and have already amassed a total of 37 c